Lundbeck and Alder BioPharmaceuticals announce updated information in the tender offer materials filed with SEC
Updated tender offer materials provide additional summary information regarding existing Lundbeck offer terms, including existing CVR terms, and additional information regarding existing Alder director and officer share ownership Offer terms remain …